Test Directory

Back to List

Cancer Antigen 125

Loinc

Expected Turnaround

24 hours

Information

This immunoassay is indicated for use as an aid in the detection of residual or recurrent ovarian carcinoma.

Collection Information

Methodology

Electrochemiluminescence-immunoassay (ECLIA)

Limitations

Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.

Rejection Criteria

Gross hemolysis, Gross Lipemia

Specimen Stability

Refrigerated: 5 days Frozen: 6 months

Alias

Cancer Antigen 125; Carbohydrate antigen 125; CA 125; CA125 (Cancer Antigen 125); CA25; Ovarian Cancer-Related Antibodies; Cancer Ag 125 (CA 125), Serum

Container Type

Serum, gel separator, SST

Minimum Volume

1 ML

Age Range

0 - 999

Sex

Generic

Units of Measure

Reference Range

- 38.1

Panic Range